Yang Ding

9.3k total citations · 1 hit paper
108 papers, 6.9k citations indexed

About

Yang Ding is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Yang Ding has authored 108 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 33 papers in Biomaterials and 33 papers in Biomedical Engineering. Recurrent topics in Yang Ding's work include Nanoparticle-Based Drug Delivery (29 papers), Nanoplatforms for cancer theranostics (27 papers) and RNA Interference and Gene Delivery (20 papers). Yang Ding is often cited by papers focused on Nanoparticle-Based Drug Delivery (29 papers), Nanoplatforms for cancer theranostics (27 papers) and RNA Interference and Gene Delivery (20 papers). Yang Ding collaborates with scholars based in China, United States and Australia. Yang Ding's co-authors include Shan Dong, Liping Wei, Lei Kong, Jiaju Huang, Jianmin Wu, Chuan‐Yun Li, Ge Gao, Xizeng Mao, Chen Xie and Jianping Zhou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Advanced Materials.

In The Last Decade

Yang Ding

100 papers receiving 6.9k citations

Hit Papers

KOBAS 2.0: a web server for annotation and identification... 2011 2026 2016 2021 2011 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases
    2011 3.8k citations Yang Ding et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yang Ding China 35 3.4k 1.3k 956 873 796 108 6.9k
Zhongjian Chen China 48 3.4k 1.0× 956 0.8× 856 0.9× 284 0.3× 782 1.0× 264 7.7k
Jiajia Liu China 38 3.3k 1.0× 714 0.6× 385 0.4× 681 0.8× 405 0.5× 234 6.3k
Annie John United Arab Emirates 26 5.4k 1.6× 1.7k 1.3× 608 0.6× 341 0.4× 320 0.4× 61 11.0k
Fei Wang China 45 4.2k 1.2× 1.9k 1.5× 418 0.4× 711 0.8× 252 0.3× 462 9.2k
Wei Shen China 41 2.7k 0.8× 1.0k 0.8× 1.2k 1.2× 679 0.8× 379 0.5× 239 8.0k
Weiwei Chen China 36 3.2k 0.9× 1.2k 1.0× 460 0.5× 589 0.7× 151 0.2× 226 5.3k
Sangdun Choi South Korea 49 3.9k 1.2× 661 0.5× 391 0.4× 677 0.8× 253 0.3× 185 8.0k
Zichun Hua China 43 3.8k 1.1× 305 0.2× 802 0.8× 869 1.0× 306 0.4× 300 7.6k
Thierry Rabilloud France 50 6.2k 1.8× 753 0.6× 846 0.9× 293 0.3× 278 0.3× 181 9.9k

Countries citing papers authored by Yang Ding

Since Specialization
Citations

This map shows the geographic impact of Yang Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Ding more than expected).

Fields of papers citing papers by Yang Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Ding. The network helps show where Yang Ding may publish in the future.

Co-authorship network of co-authors of Yang Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Ding. A scholar is included among the top collaborators of Yang Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Ding. Yang Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Ying, Qin Ma, Jun Zhang, et al.. (2025). Endogenous Iron(II) Self-Enriched Fenton Nanocatalyst via FTH1 Activity Inhibition and Iron(III) Reduction for Amplified Cancer Ferroptosis Therapy. Molecular Pharmaceutics. 22(3). 1568–1583. 1 indexed citations
3.
Liu, Lu, Yang Ding, Haoting Chen, et al.. (2025). Harnessing the Immunomodulation of UV‐Exposed Keratinocyte Extracellular Vesicles for Inflammatory Disorder Treatment. Advanced Science. 12(36). e01517–e01517.
4.
Cheng, Hao, et al.. (2024). Synergistic Target‐Attacking Tumor Cells and M2 Macrophages via a Triple‐Responsive Nanoassembly for Complete Metastasis Blocking. Advanced Healthcare Materials. 14(3). e2304096–e2304096. 3 indexed citations
5.
Song, Mingjie, et al.. (2024). Amyloid-β-targeting immunotherapies for Alzheimer's disease. Journal of Controlled Release. 375. 346–365. 20 indexed citations
6.
Song, Wenqin, et al.. (2024). Intratumoral lactic acid neutralization strategy for boosting chemoimmunotherapy using liposomal sodium bicarbonate. Science Bulletin. 69(24). 3936–3948. 4 indexed citations
7.
Wang, Shihao, Lifeng Liu, Limin Tian, et al.. (2024). Elucidation of Spatial Cooperativity in Chemo‐Immunotherapy by a Sequential Dual‐pH‐Responsive Drug Delivery System. Advanced Materials. 36(26). e2403296–e2403296. 20 indexed citations
8.
Cheng, Hao, Xin Chen, Mingjie Song, et al.. (2023). Perovskite-derived pro-photosensitizer enables sustainable photodynamic therapy in hypoxia tumors. Chemical Engineering Journal. 468. 143457–143457. 6 indexed citations
9.
Du, Yawei, Jiancheng Zheng, Zhengwei Cai, et al.. (2023). Oral Administration of Multistage Albumin Nanomedicine Depots (MANDs) for Targeted Efficient Alleviation of Chronic Inflammatory Diseases. Advanced Functional Materials. 33(9). 30 indexed citations
10.
11.
Song, Tingting, Mingjie Song, Qian Jia, et al.. (2022). Fluoropolymers-mediated efficient biomacromolecule drug delivery. SHILAP Revista de lepidopterología. 14. 100123–100123. 10 indexed citations
12.
Zhang, Xin, Xiuting Liu, Wei Zhou, et al.. (2021). Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance. Cellular and Molecular Gastroenterology and Hepatology. 12(4). 1179–1199. 60 indexed citations
13.
Cheng, Xiamin, Jing Gao, Yang Ding, et al.. (2021). Multi‐Functional Liposome: A Powerful Theranostic Nano‐Platform Enhancing Photodynamic Therapy. Advanced Science. 8(16). e2100876–e2100876. 155 indexed citations
14.
Cheng, Hao, Yue Han, Yi Jin, et al.. (2021). Natural discoidal lipoproteins with tiny modification for tumor extracellular dissociation in antitumor chemoimmunotherapy. Biomaterials. 275. 120859–120859. 6 indexed citations
15.
Yang, Yunjia, Yang Ding, Mengdi Yang, et al.. (2019). Absent in melanoma 2 suppresses epithelial‐mesenchymal transition via Akt and inflammasome pathways in human colorectal cancer cells. Journal of Cellular Biochemistry. 120(10). 17744–17756. 11 indexed citations
16.
Han, Yue, Ziqiang Zhao, Huaqing Zhang, et al.. (2018). Immune lipoprotein nanostructures inspired relay drug delivery for amplifying antitumor efficiency. Biomaterials. 185. 205–218. 38 indexed citations
17.
Liu, Xiuting, Wei Zhou, Xin Zhang, et al.. (2018). 1‐L‐MT, an IDO inhibitor, prevented colitis‐associated cancer by inducing CDC20 inhibition‐mediated mitotic death of colon cancer cells. International Journal of Cancer. 143(6). 1516–1529. 48 indexed citations
18.
Zhang, Xin, Xiuting Liu, Wei Zhou, et al.. (2018). Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2. Cell Death and Disease. 9(2). 190–190. 34 indexed citations
19.
20.
Ding, Yang. (2012). Study of different extracts from water caltrop shells on inhibiting lung cancer cell line A549. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhongjian Chen Breakdown of academic impact, for papers by Jiajia Liu Breakdown of academic impact, for papers by Annie John Breakdown of academic impact, for papers by Fei Wang Breakdown of academic impact, for papers by Wei Shen Breakdown of academic impact, for papers by Weiwei Chen Breakdown of academic impact, for papers by Sangdun Choi Breakdown of academic impact, for papers by Zichun Hua Breakdown of academic impact, for papers by Thierry Rabilloud
Rankless by CCL
2026